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The electrophysiological behavior of the zebrafish heart is very similar to that of the
human heart. In fact, most of the genes that codify the channels and regulatory
proteins required for human cardiac function have their orthologs in the zebrafish. The
high fecundity, small size, and easy handling make the zebrafish embryos/larvae an
interesting candidate to perform whole animal experiments within a plate, offering a
reliable and low-cost alternative to replace rodents and larger mammals for the study
of cardiac physiology and pathology. The employment of zebrafish embryos/larvae has
widened from basic science to industry, being of particular interest for pharmacology
studies, since the zebrafish embryo/larva is able to recapitulate a complete and
integrated view of cardiac physiology, missed in cell culture. As in the human heart, IKr
is the dominant repolarizing current and it is functional as early as 48 h post fertilization.
Finally, genome editing techniques such as CRISPR/Cas9 facilitate the humanization
of zebrafish embryos/larvae. These techniques allow one to replace zebrafish genes by
their human orthologs, making humanized zebrafish embryos/larvae the most promising
in vitro model, since it allows the recreation of human-organ-like environment, which
is especially necessary in cardiac studies due to the implication of dynamic factors,
electrical communication, and the paracrine signals in cardiac function.
Keywords: orthologs, arrhythmia, ECG, patch clamp, pharmaceutical, action potential
INTRODUCTION
Mouse is often the first-choice animal model for the study of normal and pathological heart
function. However, at the electrophysiological level, the heart of rodents and humans has important
functional differences, such as the fact that basal heart rate is more than eight times faster in mice.
The murine cardiac action potential (AP) is very short and lacks the characteristic plateau phase
of the human AP. Importantly, cardiac repolarization in humans depends mainly on the hERG
potassium channel, which is almost absent in the murine heart (Curran et al., 1995; Sanguinetti
et al., 1995; Trudeau et al., 1995; Xu et al., 1999; Rosen, 2000; Carmeliet, 2004). These limitations
have made necessary the search for alternative or complementary model organisms that resemble
better some aspects of the human cardiac physiology and pathology.
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The small size of the zebrafish (Danio rerio) (adults reach a
length of 2–3 cm), easy manipulation, efficient housing, and fast
reproduction make it a suitable model for large-scale screenings
for research and industry purposes. Another advantage is the
possibility they offer to carry out efficient gene targeting methods
and high-resolution real-time imaging methods in live fish. It
also makes possible to perform large-scale screens of an entire
organism, including toxicological, teratogenic, and ecotoxicity
studies (Ellis et al., 2014; Zakaria et al., 2018; Cassar et al., 2020).
Orthologs for about 70% of the human genes have been found in
zebrafish (Howe et al., 2013). The humanization of the zebrafish,
by replacing endogenous genes with their human orthologs,
enables the recapitulation of several human pathologies, as well
as the study of drug toxicity and efficacy in a more precise way
(Cornet et al., 2018).
Due to the advantages offered by this experimental model, the
zebrafish, initially used for studying the genetics of development
and organogenesis, has become a very useful model to study a
variety of human pathologies including cancer (Terriente and
Pujades, 2013), metabolic diseases such as diabetes or obesity
(Zang et al., 2018), neurological and neuropsychiatric diseases
(Ijaz and Hoffman, 2016), cardiac pathologies, cardiotoxicity, and
drug discovery (Gut et al., 2017; Cassar et al., 2020). The cardiac
pathologies include those that affect both the structure and the
mechanical functioning of the heart (cardiomyopathies, heart
failure (HF), myocardial injury and regeneration, or structural
and congenital heart diseases) as well as those that affect the
electrical functioning and, therefore, can cause arrhythmias (long
QT syndrome, short QT syndrome, Brugada syndrome, sick sinus
syndrome, or atrial fibrillation).
Although the zebrafish has a two-chambered heart, with
one atrium and one ventricle, the basic electrical properties
are very similar to those of the human heart. The cardiac
impulse, generated in the sinoatrial (SA) node, pauses at the
atrioventricular (AV) junction and then is conducted from apex
to base before spreading through the ventricle (Sedmera et al.,
2003; Chi et al., 2008). Finally, the morphology and behavior of
the zebrafish cardiac AP is similar to that of humans, with a long
plateau phase and a clear rate dependence (Nemtsas et al., 2010).
Thanks to the high fecundity of the zebrafish (can lay 50–500
eggs per mating), embryos are readily available (Gut et al., 2017).
The heart of zebrafish embryos starts beating approximately at
24 h post fertilization (hpf) and the blood circulates through
major vessels by 36 hpf (Stainier et al., 1996). The transparency
of zebrafish embryos/larvae makes it possible to observe the
developing internal organs (including the heart) under the
microscope (see Figure 1 from Crowcombe et al., 2016). On
the other hand, mutants with abnormal phenotypes in heart
beating and circulation defects led to the identification of genes
that are crucial for cardiac morphogenesis and cardiovascular
function (Chen et al., 1996; Stainier et al., 1996). In addition, the
characterization of ionic channels responsible for the cardiac AP
in the early zebrafish embryos/larvae (Alday et al., 2014) further
supported its use for studying human cardiac diseases.
The increasing use of the zebrafish embryo/larva not only in
basic but also in applied research can be explained by the need
for biomedical and pharmaceutical industries to have simple,
low-cost biological models, able to recapitulate in a dish a
tissue-like environment, something that is essential in cardiac
research. In the last years, the development of high-throughput
platforms and softwares to do cardiac electrophysiological studies
using zebrafish embryos/larvae has provided novel approaches to
perform non-invasive cardiac assays aimed to do drug screening
(Letamendia et al., 2012; Parker et al., 2014; Fuad et al., 2018; Gaur
et al., 2018; Sharma et al., 2018).
ELECTROPHYSIOLOGY OF THE
ZEBRAFISH
Basal Electrocardiogram, Similar to That
of Humans
Electrocardiogram has been the most extensively used routine
technique for the evaluation of human cardiac diseases.
Similarly, it has become a powerful tool for recording cardiac
activity in vivo, as well as ex vivo in isolated hearts under
Langendorff perfusion, in a number of laboratory animal
models. These include medium-size fish like carp and tilapia
(Yoshikawa et al., 1988). Milan et al. (2006) developed a
method for recording in vivo the electrocardiogram of the
small adult zebrafish. Unlike previous assays, limited to
the visualization of the hearth rhythm in the transparent
embryo (Milan et al., 2003), electrocardiography allowed for a
detailed analysis of the cardiac depolarization, repolarization,
and conduction, based on quantification of PR, QRS, or
QT interval durations (Milan et al., 2006). Several research
groups subsequently modified the recording technique in order
to improve the feasibility, the signal-to-noise ratio, and the
accuracy of the recordings (Liu et al., 2016; Lin et al., 2018;
Skarsfeldt et al., 2018; Zhao et al., 2019). These studies
demonstrated that, despite the evident anatomical differences
between the human and the two chambered zebrafish heart,
their electrocardiographic characteristics at baseline were highly
comparable. The similarities included clearly recognizable P,
QRS, and T waves, the QT interval duration, and slow heart
rate, closer to that on humans. The zebrafish heart also
receives autonomic innervation (Stoyek et al., 2016). Like in
humans, but not in mice, the QT duration in the zebrafish
is strongly dependent on the cardiac frequency (Milan et al.,
2006) and must be corrected for variations in heart rate (QTc).
Moreover, many of the ECG abnormalities observed in human
hearts under pathological conditions can be reproduced in
the zebrafish’s heart. Thus, in response to hyperkalemia, the
electrocardiographic behavior of the zebrafish and the human
hearts correlated: arrhythmia, AV block, widened QRS complex,
and prominent peaked T wave. Similarly, they also showed
ST segment depression and inverted T wave after myocardial
infarction (Liu et al., 2016).
Action Potential
The human cardiac AP consists of a rapid depolarization or
upstroke followed by a rapid partial repolarization or phase
1, a plateau characteristic of the AP in large mammals, a
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FIGURE 1 | Cardiac action potential (AP) in adult human, zebrafish embryo,
rat, and hiPSC-CMs and main ionic currents involved in each phase. (A) Adult
human ventricular AP profile simulated with the O’Hara-Rudy-dynamic model
following the methodology by O’Hara et al. (2011), Passini et al. (2017). (B) AP
from 48 hpf zebrafish embryo recorded by patch clamp. (C) AP from a single
rat cardiac ventricular myocyte recorded by patch clamp. (D) AP from 2D
cultured iCell2 hiPSC-CMs (Cellular Dynamics International, Madison, WI,
United States) recorded by CellOPTIQ platform (Clyde Biosciences Ltd.,
Glasgow, United Kingdom) using voltage-sensitive dyes di4-ANEPPS.
Different font sizes represent different current amplitudes.
final repolarization phase, and the recovering of the resting
membrane potential. Although this basic shape appears in
both chambers, important differences are observed between
ventricular and atrial AP.
The most currently employed models for the study of
cardiac AP are rodent, zebrafish, and, more recently, human
cardiac myocytes derived from pluripotential stem cells
(or hIPSC-CMs), which are becoming popular (Figure 1).
However, direct electrophysiological recording in hIPSC-CMs
requires a high degree of skill, so the alternative is to perform
electrophysiological studies through voltage-sensitive dyes
(Pfeiffer-Kaushik et al., 2018), despite providing relevant
functional results, lacks direct measurements of voltage data.
APs from adult zebrafish ventricular myocytes were recorded
for the first time by Brette et al. (2008) and were further
characterized by Nemtsas et al. (2010). Those pioneer works
showed that the resting membrane potential and the AP
amplitude were similar in ventricular myocytes isolated from
human and from zebrafish. Compared to human, the zebrafish
AP lacked a visible spike or phase 1, but it showed a clear plateau.
Since the resting heart rate is higher in zebrafish than in humans,
the action potential duration (APD) is shorter. As in humans
and in other larger mammals, APD shortens as the stimulation
frequency increases because of a shorter duration of the plateau
phase. Thus, the zebrafish ventricular AP resemble those of large
mammals including human, in clear contrast to the triangular
and almost rate independent APs recorded in mice and rats.
Another electrophysiological characteristic of the mammalian
heart is the different shape and duration of atrial vs ventricular
APs. This is also the case for zebrafish. Atrial AP amplitude is
similar in mouse, human and zebrafish. However, the resting
membrane potential is similar in zebrafish and human atrial
myocytes, but different in mice, being less negative than in the
atria of the latter.
The response of zebrafish heart to many pharmacological
agents also resembles that of humans. Drugs that reduced human
ventricular AP amplitude or shortened APD, such as TTX,
lidocaine, nitrendipine, or nifedipine, had similar effects in the
zebrafish ventricle (Nemtsas et al., 2010; Alday et al., 2014;
Miranda et al., 2019). Some classical hERG channel blockers like
E4031 or terfenadine prolonged AP both in the zebrafish and in
humans (Nemtsas et al., 2010; Alday et al., 2014). However, the IKs
or Ito blockers chromanol 293B, HMR 1556, and heteropodatoxin
seemed to have no effect on zebrafish ventricular AP (Nemtsas
et al., 2010; Alday et al., 2014; Ravens, 2018).
Besides, although the atrial APD is shorter in zebrafish
than in human, both species share the shortening response to
acetylcholine. This is an important characteristic of atrial but not
ventricular cardiomyocytes, shared by both zebrafish and humans
(Nemtsas et al., 2010).
Lastly, mutations and polymorphisms in cardiac ionic
channels that prolonged APD in human ventricles also prolonged
APD in zebrafish (Arnaout et al., 2007; Jou et al., 2013).
Interestingly, knockdown of zebrafish orthologous genes related
to atrial fibrillation (Neurl and Cand2) in human heart had
no effect on ventricular contractile function, but significantly
prolonged atrial APD (Sinner et al., 2014).
Cardiac Ion Channels in the Zebrafish
In the human cardiac AP, the initial upstroke is due to the
opening of Na+ channels carrying the fast inward Na+ current,
INa. Phase 1 is due to the opening of the K+ channels responsible
for the transient outward current, Ito. The plateau phase results
from the balance between the inward Ca2+ current, ICa−L, and
the outward rapidly activating delayed rectifier K+ current, IKr .
The final repolarization depends on the IKr and the inward
rectifier K+ current, IK 1, and the resting membrane potential
maintenance is mainly due to IK 1. Finally, the slowly activating
delayed rectifier K+ current, IKs, participates in the APD
adaptation to adrenergic stimulation or increased heart rate.
The ionic currents that define the cardiac AP are conducted
through specific ionic channels (Figure 1 and Table 1). In
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TABLE 1 | Ionic currents responsible for the action potential in ventricular myocytes from adult human, zebrafish embryo, adult zebrafish, adult rat, and human-induced
pluripotent stem cell-derived cardiac myocytes (hIPSC-CMs).











INa Nav1.5 Navβ Nav1.5 ?? Nav1.5 Navβ Nav1.5 Navβ Nav1.5 ??
ICa−L Cav1.2 β; α2δ Cav1.2 β; α2δ Cav1.2 β; α2δ Cav1.2 β; α2δ Cav1.2 ??
ICa−T – – Cav3.2 – Cav3.2 – – – Cav3.2 –
Ito Kv4.3 MIRP1 – – – – Kv4.3; Kv4.2 MIRP1 Kv4.3 –
IKr hERG1 hERG? hERG2 – hERG1
IKs Kv71. MinK – – Kv7.1 – – – Kv7.1 –
IK 1 Kir2.1; 2.2; 2.3 – Kir2.4 – Kir2.4 – Kir2.1; 2.2; 2.3 – Kir2.1; ??;?? –
IK – – – – – – Kv2.1 – – –
Correlation with the different pore-forming α-subunits (Channel) and accessory proteins. Different font sizes represent different expression levels.
humans, the inward INa and ICa−L are carried through Nav1.5
and Cav1.2 channels, whereas the channel-forming proteins
responsible for the outward potassium currents Ito, IKr , IKs,
and IK 1 are Kv4.3, Kv11.1 or hERG, Kv7.1, and Kir 2 (2.1, 2.2,
2.3), respectively. The zebrafish genome has orthologs of Nav1.5,
Cav1.2, and the K+ channels Kv4.3, Kv7.1, and ERG (Rottbauer
et al., 2001; Langheinrich et al., 2003; Novak et al., 2006;
McDermott et al., 2007; Hassel et al., 2008; Abbas and Whitfield,
2009; Sanhueza et al., 2009; Lovering et al., 2018), whereas
zebrafish Kir2 composition is dominated by an isoform hardly
expressed in mammalian cardiomyocytes (Kir 2.4) (Hassinen,
Minna, Jaakko Haverinen, Matt et al., 2015). However, as will
be explained later, some cardiac ionic currents may be produced
by different gene products in humans and zebrafish (Vornanen
and Hassinen, 2016), and some channels might express in non-
cardiac tissues but not in the heart (Buckingham and Ali, 2004;
Coutts et al., 2006). The pacemaker current Ih, the depolarizing
Na+ and Ca2+ currents, and the repolarizing K+ current IKr have
been recorded in the zebrafish heart (Warren et al., 2001; Brette
et al., 2008; Nemtsas et al., 2010).
Depolarizing Na+ and Ca2+ Currents
The sodium current was recorded by Warren et al. (2001) in
both atrial and ventricular myocytes from adult zebrafish hearts.
Although INa had similar amplitude in both chambers, atrial INa
has a more negative inactivation half voltage and less voltage
sensitivity than ventricular INa. In the human heart, functional
sodium channels that drive the INa consist of the pore-forming
α-subunit Nav1.5 and different Navβ regulatory subunits, coded
by the hSCN5A and the hSCN1 to 4β genes, respectively. Two
orthologs of the Nav1.5 α-subunit, zSCN5Laa and zSCN5Lab,
have been described in the zebrafish heart (Novak et al., 2006)
and share 60% to 65% amino acid identity with hSCN5A (Novak
et al., 2006; Chopra et al., 2010). Zebrafish also express single
orthologs of zSCN1 to 3β, and two different zSCN4 β genes, with
homologies with human β genes between 50 and 54% (Chopra
et al., 2007). Co-expression experiments on CHO cells showed
that zβ-subunits modified the biophysical properties, including
voltage dependence, of the sodium channel α-subunit zNav1.5
as in the heart of mammals. The atrial vs ventricular expression
of α-subunits has not been explored, but the expression of
β-subunits is clearly different, higher in ventricular than in atrial
myocytes (Chopra et al., 2007). This difference in the expression
of β-subunits could explain the biophysical differences between
atrial and ventricular INa.
As indicated above, the Ca2+ current was recorded for the first
time by Brette et al. (2008), and later characterized by Nemtsas
et al. (2010). Different stimulation protocols and pharmacological
tools demonstrated that the current was actually a combination
of the low threshold activated and Ni2+-sensitive ICa−T , and the
high threshold activated and nifedipine-sensitive ICa−L. This is
a striking difference between human and zebrafish adult hearts.
In humans, ICa−T , carried through Cav3.2 channels, contributes
to the total calcium current during embryonic development and
neonatal stage, but is absent from the adult heart (Vassort et al.,
2006), where the plateau phase is maintained only by the ICa−L,
carried through the pore-forming Cav1.2 α-subunit plus the
modulatory α2δ and β-subunits.
The hCACNA1C gene that encodes for the human Cav1.2
Ca2+ channel has two orthologs in zebrafish, named zCANA1Ba
and zCACNA1Bb (Sanhueza et al., 2009), and the Cav1.2 is
expressed at a similar degree in both zebrafish atrium and
ventricle (Haverinen, Jaakko, Minna Hassinen, Surjya Narayan,
Dash, and Matti Vornanen., 2018). Regarding the β-subunits, two
zβ2 and two zβ4 genes have been found. The homology to the
human genes in the SH3 and GK domains is 95–96% and the
majority of amino acid substitutions are conservative (Ebert et al.,
2008a,b; Chernyavskaya et al., 2012). The α2δ subunits are also
present in zebrafish genome (Howe et al., 2013), sharing a 66%
homology with human gene.
In humans, ICa−T , carried through Cav3.2 channels, is present
in the heart during embryonic development and neonatal stage,
but is absent from the adult heart (Vassort et al., 2006). A robust
ICa−T has been recorded in adult zebrafish atrial and ventricular
myocytes (Brette et al., 2008; Nemtsas et al., 2010), and the
pharmacological blockade of ICa-T strongly affects excitability in
zebrafish embryonic heart (Alday et al., 2014).
The zCACNA1G gene, which encodes for the Cav3.1 channel,
and the zCACNA1Ha (ortholog of the hCACNA1H), which
encodes for the Cav3.2 channel, are present in the zebrafish
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genome (NCBI, 2020). In adult zebrafish, Cav3.1 is the most
expressed cardiac calcium channel at the mRNA level, while
Cav3.2 is expressed 100 to 1000 times less, suggesting that
the current recorded in adult cardiomyocytes is transported by
Cav3.1 (Haverinen, Jaakko, Minna Hassinen, Surjya Narayan,
Dash, and Matti Vornanen., 2018). On the other hand,
immunofluorescence staining revealed the presence of Cav3.2
channels in atrial and ventricular myocytes from zebrafish
embryo (Alday et al., 2014).
Repolarizing K+ Currents
In both human and zebrafish, IKr is the main repolarizing current,
although the IKr is generated by non-orthologous genes in human
(KCNH2 or erg1) and zebrafish (KCNH6 or erg2) (Vornanen
and Hassinen, 2016). Despite the fact that the similarity between
both channels is very high, reaching 87% between the S1
segment and the CNBD (Cyclic Nucleotide Binding Domain),
and exceeding 99% in the pore-forming domains (Langheinrich
et al., 2003; Scholz et al., 2009), drug sensitivity is also comparable
between both species.
When zERG was heterologously expressed in xenopus oocytes,
the recorded current showed subtle differences from human
hERG in its activation and deactivation kinetics as well as
in voltage dependencies of activation and inactivation (Scholz
et al., 2009). However, Scholz et al. demonstrated in an elegant
experiment that, by applying a cardiac AP-shaped voltage
pulse, that is, simulating physiological conditions, the currents
generated by the zERG and hERG channels were almost
identical (Scholz et al., 2009). For all the above evidence, the
zebrafish heart is currently considered a good model for studying
the ERG channel.
Although the K+ channel Kv4.3 gene KCND3 has been found
in zebrafish genome (Lovering et al., 2018), the corresponding
cardiac Ito current has never been recorded (Nemtsas et al.,
2010). This supports the idea that the channel may be present
in non-cardiac tissues and not in the heart. In this sense, the
A-type outward current, equivalent to cardiac Ito, was recorded
in skeletal but not in cardiac myocytes (Coutts et al., 2006).
Regarding Kv7.1 channels and IKs current, the results are
controversial. Current recordings using patch-clamp technique,
immunostaining of the channel, and APD inhibition experiments
using specific blockers failed to find evidence of IKs in the adult
and in the embryonic zebrafish hearts (Nemtsas et al., 2010;
Alday et al., 2014). However, using a different technique to isolate
cardiac myocytes, Abramochkin et al. (2018) recently showed that
IKs is present in adult zebrafish ventricular myocytes. Human
IKs is formed by the Kv7.1 channels together with the β-subunit
MinK (Barhanin et al., 1996; Sanguinetti et al., 1996). The
zebrafish heart expresses both the zKCNQ1 and zKCNE1 genes,
encoding zKv7.1 and zMinK, respectively (Vernlund, 2011; Wu
et al., 2014; Lovering et al., 2018). However, the low expression
ratio of MinK in the zebrafish heart indicates that the current
is mainly carried through Kv7.1 channels only. This absence of
MinK in the channel complex can explain why the current kinetic
is faster in the zebrafish than in the human heart (Abramochkin
et al., 2018). In addition, it also explains why IKs blockers have no
effect on the zebrafish AP, since the channel sensitivity to these
compounds depends on the presence of this β-subunit (Busch
et al., 1997; Lerche et al., 2000; Bett et al., 2006).
Background Channels
Genes responsible for the atrium-specific small conductance
Ca2+-activated K+ SK channels, KCa2.1-3 (KCNN1, KCNN2,
KCNN3); for the leak channels TASK1 and TASK3 (KCNK3 and
KCNK9); and the acetylcholine−activated current, IKACh, (KCNJ3
and KCNJ5) have been reported in adult zebrafish heart. However,
direct current recordings have shown that the acetylcholine-
activated inwardly rectifying current, IKACh, is functional and
significant in the zebrafish atrium, whereas TASK and SK
channels are not relevant for the regulation of the atrial AP
(Skarsfeldt et al., 2018).
ZEBRAFISH AS A MODEL FOR
CONGENITAL AND ACQUIRED LONG QT
SYNDROME (LQTS)
Long QT syndromes result in an excessive QTc interval duration
(>450 ms in males and>460 ms in females), an indicator of
high susceptibility to develop arrhythmia like torsade de pointes,
ventricular fibrillation, and sudden death (Schwartz and Crotti,
2011). Congenital mutations that affect the functioning of cardiac
ion channels lead to inherited LQTS, which affects around
1/5000 people worldwide. Although mutations in Na+, Ca2+,
and different K+ channels can lead to LQTS, loss-of-function
mutations in KCNQ1 or HERG are responsible for over 90% of
the cases of inherited QT syndrome.
Besides, acquired LQTS can result from the use of drugs
that block ionic channels but, in clinical practice, it is
caused mainly by drugs that reduce the hERG-channel current
(Sanguinetti and Tristani-Firouzi, 2006).
The zebrafish is an interesting animal model for the study
of human LQTSs. In the zebrafish, mutations that reduced IKr
current also induced prolongation in the QT interval. This is
the case of the Zebrafish breakdance or bre mutant, the first
mutation described in the zebrafish ERG (zERG), and the best
characterized (Langheinrich et al., 2003). The bre zebrafish has
a zERG-I59S mutation that reduced ERG protein trafficking to
the membrane and, therefore, prolonged cardiac repolarization
and QT interval duration in homozygosis (Meder et al., 2011;
Liu et al., 2016). Two other mutations, I462R and M521K,
also prolonged repolarization and led to LQTS in the zebrafish
(Arnaout et al., 2007).
Regarding acquired LQTS, almost 100% of cases are caused
by the blockade of the hERG channel by different and unrelated
drugs (Sanguinetti and Tristani-Firouzi, 2006). It is important to
highlight that the high sensitivity of hERG to be blocked by a
wide variety of compounds is due to two specific amino acids,
tyrosine at position 652 (Y652) and, especially, phenylalanine
at position 656 (F656) (Mitcheson et al., 2000). Both amino
acids locate in equivalent positions in the zERG ortholog
(Y624 and F628) (Langheinrich et al., 2003). Therefore, classical
hERG pharmacological blockers prolonged QT in the zebrafish,
whereas non-prolonging drugs in humans showed no effect in
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the fish (Milan et al., 2006). Moreover, given the interest of
the human potassium channel hERG as a source of acquired
LQTS, most of the studies carried out on the zebrafish heart
aimed to test the potential cardiotoxicity of novel drugs on
cardiac hERG (Langheinrich et al., 2003; Mittelstadt et al., 2008;
Shi et al., 2009).
THE ZEBRAFISH EMBRYO AND LARVA
FOR THE STUDY OF CARDIAC
ARRHYTHMIA
Cardiogenesis of the Zebrafish
Classically, teleosts are considered embryos until they hatch.
Since hatching can occur over a wide period of time, ranging
between 48 and 72 hpf in the case of zebrafish, it is difficult
to define exactly the transition between embryo and larva
(dechorionated embryo). Kimmel et al. (1995) established the
end of embryonic period at 72 hpf, when the protruding mouth
stage was attained. Cardiogenic differentiation for the future
ventricle cells starts after 16 hpf, while in the future atrial cells,
it occurs around 22 hpf, with the formation of a linear heart
tube at 30 hpf (Bakkers, 2011). The heart begins to beat with no
apparent direction at the onset of the pharyngula period (24–
48 h), and at 26 hpf, the contraction occurs, which takes place
in two parts, reflecting the development of the two chambers.
At 36 hpf, the blood circulates, and the heart starts to bend,
with the heart bending more prominent at 42 hpf. By this time,
the heart beats with a rate of 180 bpm, preceding the atrial
beat to the ventricle one. At the beginning of the hatching
period (48–72 hpf), the heart tube continues bending to enhance
the dorsal positioning of the atrium relative to the ventricle,
and by then, the six pairs of aortic arches are present but
not all are functional until the Pec-fin stage (60 hpf), when
blood flows into all of them and through the subclavian loop
(Kimmel et al., 1995).
It is well-known that vertebrate multichambered hearts
required the coordination of their heart chambers to achieve
the efficient blood flow throughout the organism. To achieve
this, the cardiac conduction system (CCS) plays an essential
role. Between 20 and 24 hpf, and prior to the beginning of
the pharyngula period, when the heart starts its contractile
activity, a linear conduction travels through the heart tube
from the sinus venosus to the outflow tract, suggesting the
presence of a SA nodal pacemaker activity. A significant delay
in AV conduction is reported during chamber formation (36–
48 hpf), and a rapid immature conduction network develops
within the ventricle as the heart loops are made (72–96 hpf).
Finally, at 21 dpf, a fully mature conduction pathway through
ventricular trabeculae (equivalent of the His-Purkinje system),
which allows fast apex-to-base activation pattern, is formed
(Chi et al., 2008). Interestingly, through molecular identification
using the marker islet-1, the triggering place of the pacemaker
activity can be determined (Tessadori et al., 2012). Whereas
in the adult zebrafish the primary pacemaking site occurs at
the sinus venosus-atrial junction, propagating from there to the
ventricle during atrial diastole (Tsutsui et al., 2010), in 3 dpf
zebrafish, it is located in the right dorsal quadrant of the SA ring
(Arrenberg et al., 2010).
Cardiac Electrophysiology of the
Zebrafish Embryo/Larva
The phylogenetic distance between fish and mammals is minimal
in early developmental stages, when different vertebrate groups
share general features, including cardiac function. For this
reason, the use of zebrafish embryos/larvae, rather than adult
specimens, provides a good model to perform cardiac physiology
studies (Matrone et al., 2015).
In contrast to the adult zebrafish, due to the small size of the
heart and the low signal-to-noise ratio in the early embryo/larva,
electrocardiographic recordings are very uncommon. Forouhar
et al. (2004) were able to record in vivo the ECG of zebrafish larvae
at 5 days post fertilization (dpf) using micropipette electrodes,
which differs from the existing methodology to study cardiac
function in embryos/larvae, mainly based on optical mapping
using voltage- and calcium-sensitive dyes, with limitations such
as dye cytotoxicity, photobleaching, and low temporal resolution
(Tamaddon et al., 2000). Five dpf larvae showed bimodal ECG,
with atrial and ventricular depolarization waves (P and R waves,
respectively) (Forouhar et al., 2004). Yu et al. (2010) established
the dynamic changes of zebrafish larvae during developmental
stages; thus, ECG revealed P waves and QRS complexes at 7
dpf, the T wave appeared at 14 dpf, and the three elements (P
and T waves and QRS complex) adopted adult characteristics at
35 dpf. The effect of the antiarrhythmic drug amiodarone has
been shown at the different stages as a prolongation of QRS
interval, probably due to the blockade of the fast inward Na+
current (INa), which causes a decrease of dV/dt (Yu et al., 2010).
Later, Dhillon et al. were able to record all the components of
the ECG (P, QRS, and T waves) in 48 hpf–5 dpf embryos/larvae
using a microelectrode approach similar to that mentioned above
(Dhillon et al., 2013).
In contrast to the difficulties to record ECGs, the transparency
of the zebrafish embryos/larvae makes the direct observation of
the heart beating pattern and the study of alterations in rhythm
possible. That makes the zebrafish embryos/larvae a suitable
model for the study of either congenital or acquired LQTS.
In the zebrafish heart, atrium and ventricle beat coordinately
with a 1:1 ratio. Screens for early developmental mutants
identified mutations that led to severe arrhythmic phenotype,
like the hiphop (hip) mutant embryo, whose beating pattern is
3:1 (the atrium contracts three times, but the ventricle once),
or several mutants with fibrillating hearts (Chen et al., 1996).
The previously mentioned breakdance (bre) mutant embryo
has a beating pattern of 2:1 (Chen et al., 1996). Drugs that
induced acquired LQTS in humans and in adult zebrafish caused
bradycardia and 2:1 AV block in the embryo (Milan et al., 2003;
Kopp et al., 2005). Knockdown of zERG function in the zebrafish
embryo, as occurs in congenital LQT syndrome, caused similar
effects (Langheinrich et al., 2003; Milan et al., 2003; Kopp et al.,
2005; Arnaout et al., 2007). In humans, 2:1 functional AV block
was reported in a newborn child with severe congenital LQTS,
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caused by homozygous mutations in hERG that led to absence of
functional IKr (Hoorntje et al., 1999).
Although adult zebrafish have been used for the in vivo
characterization of LQTS inducing mutations, unfortunately,
most of these mutations, especially when expressed
homozygously, create non-viable adult animals. Zebrafish
embryos/larvae have the capacity of surviving without
cardiovascular function up to 4 days (Hu et al., 2000), due to
their ability to obtain oxygen by diffusion from the environment
(Rottbauer et al., 2005). Thanks to this characteristic, it is
noteworthy that the cardiac activity can be monitored in
zebrafish embryos/larvae carrying lethal mutations up to late
larval stages, while this causes in utero death in placental animals.
Thus, as a part of a study of the LQTS mutations I462R and
M521K of the zERG channel, Arnaout et al. recorded for the
first time APs in atria and ventricle 48 hpf and demonstrated
that the zebrafish embryo is a good model for the study of ERG
dependent arrhythmia (Arnaout et al., 2007).
Another example of lethal mutations described in zebrafish
is the dead beat (ded) (Stainier et al., 1996), which affects
phospholipase Cγ1 gene (PLCγ1). A recent study has described
the key role of PLCγ1 mutation in maintaining ventricular
contractility in the zebrafish embryo. In ded mutant, the
ventricular contractility declines over time, stopping by 60
hpf (Rottbauer et al., 2005). Further studies need to be done
to understand the downstream cascade of PLCγ1 involved in
contractility, although it seems to be mediated by the increase
in Ca2+ stores by IP3. Finally, due to the fact that PLC
functions downstream of FLT1 (gene of the vascular endothelial
growth factor receptor 1—referred to as VEGFR1), and since the
homology of hFLT-1 and zFLT-1 is high (∼51%), these findings
could open a new insight into the treatment of HF exploring
the VEGF–PLCγ1 pathway. It would suppose an alternative to
the current treatments, aimed at improving cardiac contractility
through changes in Ca2+ handling, which carry the risk of
inducing arrythmias.
Regarding the cardiac AP, characteristics of the ventricular AP
and the ionic channels responsible for the electrical activity in
zebrafish embryos/larvae have been described at three different
developmental stages: 48, 72, and 96 hpf (Alday et al., 2014).
Thus, in zebrafish embryos/larvae, pharmacological inhibition
demonstrated that the AP upstroke depends on both Na+- and
T-type Ca2+ currents, and the plateau phase depends on L-type
Ca+2 channels. The AP repolarization and diastolic potential
depends on ERG K+ channels. Immunofluorescence staining
confirmed the presence of the channels observed in adult Nav1.5,
Cav1.2, Cav3.2, and ERG in the embryonic/larval heart. Another
common feature of embryonic and adult APs is the absence of a
spike and dome shape, mainly because of the absence of phase 1.
Again, no effect was observed after pharmacological blockade and
in immunostaining experiments, indicating that human Ito and
IKs are absent from the heart of the embryonic/larval and adult
zebrafish (Nemtsas et al., 2010; Alday et al., 2014). As mentioned
above, IKs develops later and is only present in adult ventricle
(Abramochkin et al., 2018).
Finally, in studies with the zebrafish mutant slow mo (smo),
named for its slow heart rate, the T-type Ca2+ current, the
rapid delayed rectifier K+ current, IKr , and the hyperpolarization-
activated pacemaker Na+ and K+ current, Ih, have been recorded.
The reduction of the Ih caused the low heart rate of the slo mo
mutant (Baker et al., 1997).
ZEBRAFISH EMBRYOS/LARVAE FOR
THE STUDY OF CARDIAC PATHOLOGIES
AND THEIR THERAPIES
Whole animal experimental models are essential to understand
the molecular mechanisms of diseases and are key to validate
the therapeutic potential of new drug entities. Opposite to
in vitro and ex vivo models, they offer a complete and
integrated view of animal physiology, covering important
issues such as drug absorption, distribution, metabolism,
and excretion (ADME), which are missed in cell culture.
Zebrafish has emerged as an alternative to conventional
in vivo mammal models, which are more expensive and
time-consuming, and therefore are restricted to late stages of
drug screening (Delgado et al., 2004). The fact that zebrafish
embryos/larvae can be maintained at high densities, together
with the straightforward procedure for drug administration,
make them suitable for high-throughput assays, enhancing the
efficiency of several steps during drug development process
(Zon and Peterson, 2005).
Since zebrafish has morphological and molecular bases
of tissues and organs similar to humans, including heart,
it could provide a good model to study cardiac pathologies
and drug responses. Zhu et al. (2014) used the zebrafish
embryo (48 hpf) treated with verapamil as a HF model to
evaluate potential therapeutic agents. They found that a
30-min treatment with 200 µM of verapamil is the optimal
condition for inducing changes in the cardiovascular system,
compatible with those observed in human HF (pericardial
edema, venous blood congestion, reduced cardiac output,
and slowed blood flow) (Zhu et al., 2014). Eight therapeutic
drugs for HF treatment, approved either by the USA Federal
Drug Administration (FDA) (LCZ696, digoxin, irbesartan,
metoprolol, enalalpril, and hydrochlorothiazide) or by China’s
State Food and Drug Administration (CFDA) (qiliqiangxin
capsule and shenmai injection), were tested. The eight
drugs significantly reduced HF in the zebrafish embryo
after 4.5 h of treatment, demonstrating the suitability of
this model to screen HF drugs, saving time, and reducing
costs and drug attrition at later stages of drug development
(Zhu et al., 2018).
Zou et al. established a novel hypoxia/reoxygenation
(H/R) model in zebrafish larvae to simulate myocardial
ischemia/reperfusion injury (MIRI) as an alternative for in vivo
screening of MIRI therapeutics. The optimal conditions to
simulate MIRI consisted of 48 h of hypoxia followed by 2–
5 h of reoxygenation. Besides heart dysfunction, they found
upregulation of myocardial injury markers such as cardiac
troponin (TNNT2), ventricular natriuretic peptide, and hypoxia-
inducible factor 1-alpha (HIF1α), and increased red blood cells
(Zou et al., 2019).
Frontiers in Physiology | www.frontiersin.org 7 January 2021 | Volume 11 | Article 607860
fphys-11-607860 January 4, 2021 Time: 15:55 # 8
Echeazarra et al. Cardiac Electrophysiology of Zebrafish Embryos/Larvae
ADULT ZEBRAFISH AND ZEBRAFISH
EMBRYOS/LARVAE IN INDUSTRY
Traditionally, two types of screening tests have been used during
the drug discovery process by the pharmaceutical industry. The
first one, a purely in vitro approach, consists on identifying
potential drug candidates based on their ability to bind molecular
targets. The second one is a phenotypic screening with the
objective of identifying drugs capable of modifying a disease
phenotype, following in vitro or in vivo methodologies (cells,
tissues, or whole organisms) (Swinney and Anthony, 2011). The
phenotypic screening is a very reliable strategy and used to be
the mainstay of drug development, with the inconvenience of
slowing down the pipeline due to the difficulties to find out what
targets are being achieved. For this reason, the pharmaceutical
industry focused its efforts on target-based approaches, which
are faster even though they have a lower success rate. Zebrafish
belongs to this second group (phenotypic assays). The innovation
reached within in silico and in vitro target identification has
brought phenotypic assays back in trend (Kotz, 2012).
Zebrafish offers an in vivo model to perform comprehensive
toxicological and long-term efficacy tests, as well as safety studies
before moving to the clinical phase, filling the gap found between
in vitro and in vivo tests reported by the pharmaceutical industry
(Parker et al., 2014). Besides, zebrafish embryos/larvae have an
extra advantage compared to adult specimens: the employment of
larvae up to 5 dpf represents a replacement alternative in animal
research (Dhillon et al., 2013) and, therefore, has a direct impact
in the Replacement, Reduction and Refinement (3Rs) strategy,
an essential aspect to fulfill the ethical standards required in the
pharmaceutical and chemical industries (Avey et al., 2015).
Zebrafish for Studying Drug Toxicity
Probably, the most widespread use of the zebrafish embryo/larva
in industry is the evaluation of potential toxicity of chemicals
and drugs. The small size of the embryo/larva provides a
system where only a minimal amount of water-soluble chemicals
is required and can be directly added to the embryos/larvae
(Aspatwar et al., 2019). The compounds with poor water
solubility, however, need to be injected into the fish to ensure
enough exposure. The negative consequence of this feature
is the reduction of the chemical pool to be tested and,
therefore, the experimental throughput (Cassar et al., 2020).
The main advantage of the zebrafish embryo/larva lies in the
possibility to offer an economic and quick assessment in a
whole vertebrate organism covering the entire organogenesis
period, supposing an alternative to commonly used ex vivo
models such as whole embryo culture or embryonic stem cells
(Cassar et al., 2020).
Dhillon et al. optimized the recording of ECG in zebrafish
larvae to perform reliable cardiotoxicity assays. The assay
was sensitive and specific to detect drug-induced changes in
QT intervals, and the results were reliable, reproducible, and
compatible with those obtained from adult zebrafish (widening
of QRS complex and T wave). The drugs terfenadine and
haloperidol prolonged the QT interval and caused 2:1 AV block
with similar features to those observed in humans. Therefore,
the assessment of ECG in zebrafish embryos/larvae could be a
good surrogate for cardiac dysfunction in humans. Since zERG
seems to be more sensitive to QT prolonging drugs than hERG,
the aforesaid approach could be a good alternative to test the
cardiotoxicity of drugs in development (Dhillon et al., 2013).
Ecotoxicity Studies
One area of research with zebrafish is the study of the adverse
effects of xenobiotics on animal growth and development. For
decades, zebrafish embryos/larvae have been used as biosensors
in ecotoxicity studies to test the presence of contaminants
and to understand how environmental endocrine disruptors,
contaminants and drugs affect human development and health
(Vliegenthart et al., 2014; Aluru, 2017; Aedo et al., 2019; Silveira
et al., 2019). The model is useful to study the cardiac toxicity
induced by pollutants from embryonic to adult stages, showing
cardiac malformations and changes in heart rate and in ejection
fraction (Wang et al., 2020). These environmental toxicity assays
are often performed with zebrafish embryos in combination
with other standard models such as Daphnia magna and algae
(Clements et al., 2012), while adult fish are kept for evaluating
behavioral toxicity (Chagas et al., 2019).
Evaluation of Teratogenic Potential of Drugs
During the drug development process, prior to the marketing
of drugs, it is also necessary to evaluate teratogenic potential
as part of the safety studies. The employment of zebrafish
embryos/larvae has the advantage of providing both drug
cardiovascular toxicity and cardiovascular development effects
(Chang et al., 2014; Caballero and Candiracci, 2018). Teratogenic
studies are done in embryos/larvae from 5 to 96 hpf, covering
from late blastula/early gastrula stages to fully developed organs
(Beekhuijzen et al., 2015). The most remarkable parameters
obtained from hemodynamic evaluation are beating rate, cardiac
output, fractional area change, and shortening and blood
flow velocity (Shin et al., 2010). Functional analysis includes
evaluation of heart pumping efficiency, while structural analysis
provides information about the heart size. These studies require
rapid imaging techniques, as well as robust software to process
the information (Zakaria et al., 2018).
Cardiotoxicity Studies
Several laboratories offer, in addition to global safety studies
(Cornet et al., 2017), specific studies to test the potential toxicity
on particular organs like the heart (Alzualde et al., 2018). For
cardiovascular drug toxicity, the zebrafish embryos/larvae allow
a more reliable prediction of cardiotoxicity than cellular systems
and yield similar predictive performance to previous validation
meta-studies performed with dogs, the standard preclinical
model for predicting cardiotoxic liabilities prior to clinical phases
(Dyballa et al., 2019).
Since cardiovascular physiology is conserved in humans and
zebrafish, the effect of many drugs is comparable between both
species (MacRae and Fishman, 2002). Zebrafish embryo has
been used to assess the impact of cigarette smoke, alcohol,
and recreational drugs on the cardiovascular system in order
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to understand the effects of maternal consumption during
pregnancy in the fetal development, showing alterations in heart
rate, morphology, development, and function (Ellis et al., 2014;
Mersereau et al., 2015; Li et al., 2016).
Milan et al. performed a cardiotoxicity study using a library of
100 compounds, 23 of them well-known QT prolonging drugs
in human. Their results showed that only 18 out of the 23
drugs tested induced bradycardia and AV block in zebrafish,
and the other 5 were false-negatives because the drug was not
properly absorbed. Antisense KCNH2 oligonucleotide injection
yields bradycardia in zebrafish, demonstrating the correlation
between IKr blockade and bradycardia.
Cardiotoxicity assays are performed integrating fluorescent
reporter genes into the genome of the embryos/larvae. The
resulting zebrafish express a green fluorescent protein (GFP)
in the heart, which makes the direct observation of the main
cardiac processes possible (fluorescent heart images can be
seen in Alday et al., 2014; Bloomekatz et al., 2017). GFP
transgenic embryos/larvae are incubated with the molecules
of interest and few-second videos of the beating heart are
recorded to analyze cardiac physiological functions that may
be indicative of toxicity (Hoage et al., 2012). In order to
analyze as exhaustively as possible potential cardiac dysfunctions,
some high-throughput screening platforms have been developed
to analyze and quantify the impact of drugs and diseases
in cardiac and vascular performance. These platforms usually
combine microscopic high-definition videos taken in vivo with
software analyses through advanced algorithms that allow the
quantification of multiple relevant cardiovascular parameters
like heart rate, arrhythmia, AV blockage, ejection fraction,
or blood flow (De Luca et al., 2014; Fuad et al., 2018;
Dyballa et al., 2019).
The Zebrafish as a Tool to Identify Novel
Therapies for Human Cardiovascular
Disease
Drug efficacy studies are a cornerstone in the development of new
drugs. Pharmaceutical companies are the first to be interested
in knowing the effectiveness of new compounds before reaching
clinical development, where the increase in costs is dramatically
significant. Since the zebrafish embryo/larva has the ability to
oxygenate through diffusion, mutations and diseases that cause
severe cardiac phenotypes, including non-contracting hearts, can
be analyzed (Asnani and Peterson, 2014).
On the other hand, one therapeutic area of interest to
the medical community and pharmaceutical industry is the
cardioprotection of patients at cardiovascular risk. In these
studies, zebrafish embryos with green fluorescent heart are
dechorionated and incubated with the cardiotoxic compound
doxorubicin in combination with the potentially protective
molecules of interest. At the endpoint, larval heart and vessels are
imaged and analyzed.
Finally, the regenerative capacity of the zebrafish’s heart
gives the opportunity to study therapies for heart injury and
scar formation after myocardial infarction. One interesting
research program aimed at generating new cardiac therapeutic
strategies in the field of cardiac regeneration is REANIMA1,
a Europe-wide project coordinated by the Spanish CNIC
where zebrafish play an essential role due to their capacity to
regenerate the heart. In adult mammals, including humans, the
regenerative capacity of the heart is residual and insufficient to
recover its function naturally. This EU-funded project aims at
studying, analyzing, and thoroughly describing the regeneration
mechanisms present in zebrafish to transfer them to humans, thus
addressing translating knowledge of regenerative biology from
the laboratory to clinical applications, in this case regeneration
of the heart.
Platform Development to Perform Cardiac Assays in
Zebrafish Embryos/Larvae
The demand of automated and high-throughput platforms
to allow cardiac electrophysiology studies using zebrafish
embryos/larvae has driven the efforts of research centers and
biotechnological industries to develop experimental protocols
to accurately assess cardiac function in this singular model.
The assessment of cardiac endpoints in zebrafish embryos/larvae
based on video recordings allows non-invasive, long-term in vivo
studies. These emerging approaches suppose a good alternative
for preclinical drug-discovery and toxicology studies. In the
last years, several groups have concentrated their efforts in the
development of different technologies of great utility for the
pharmaceutical industry.
Different platforms and software, such as ZebraPace
(Zebrafish Precise Algorithm for Cardiac-rhythm Estimation),
MicroZebraLabTM (v3.5, ViewPoint, Lyon, France) or
DanioVison system (Noldus Information Technology,
Netherlands), have been developed to quantify the contractility,
heart rate, incidence of arrhythmia, and blood flow in zebrafish
embryos/larvae (Parker et al., 2014; Gaur et al., 2018; Kang et al.,
2018; Wang et al., 2020).
The employment of transgenic zebrafish expressing GFP
within cardiac and/or vascular cells allows to do high-throughput
cardiotoxic assays in 5–72 hpf zebrafish embryo for the
quantification of heart rate, blood flow, and pericardial area,
among other parameters (Yozzo et al., 2013).
Most of the image-based heart rate assays are limited to
the analysis of one embryo per image field, but the challenge
of performing this assay from multiple embryos per field was
recently achieved. They have been designed different platforms
able to record and process videos in plates with multiple
embryos (2 dpf) using either bright-field or fluorescence imaging,
circumventing the need of immobilizing the specimen either by
anesthesia or dynamic force (Letamendia et al., 2012; Martin
et al., 2019). In both cases, the reliability of the results has been
compared with well-established methodologies.
To tackle the limitation due to manual manipulation
of zebrafish specimens and the need of agarose-embedding,
different groups have developed platforms integrating micro-
echocardiography, microfluidic chips, high-resolution imaging
system, and several devices for robotization. The strength of
these platforms relies on its automation and high throughput
1https://cordis.europa.eu/project/id/874764
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(10–20 embryos/larvae simultaneously) (Letamendia et al., 2012;
Fuad et al., 2018).
SUMMARY AND FUTURE DIRECTION:
HUMANIZATION OF ZEBRAFISH
The main limitation of animal models, even those with high
homology with humans, occurs in the moment of translating the
results to human biology due to the well-known inter-species
variability. Human-induced pluripotent stem cells seem to be the
closer in vitro approach to human physiology; nevertheless, the
difficulties to recapitulate in vitro the conditions of a tissue-like
environment is the Achilles heel of this model, when cultured
in 2D. The recreation of organ-like environment is especially
necessary in cardiac studies, where the dynamic factors (motion
and stretch), the electrical communication, and the paracrine
signals are essential for proper cardiac function (Giacomelli
et al., 2017). The humanization of zebrafish can be achieved
by substituting an endogenous gene with its human ortholog,
contributing to obtain solid evidences regarding drug–target
interactions (Cornet et al., 2018). This approach is especially
relevant because the percentage of human disease-related genes
with functional zebrafish orthologs is around 83% (Howe et al.,
2013) and, therefore, most of human pathologies can be faithfully
recapitulated in zebrafish. This issue, together with the fact
that the main organ implicated in drug metabolism (liver)
is functional from early development (Parng, 2005) and that
the zebrafish physiology is able to recapitulate mammalian
drug metabolism characteristics (ADME), makes the zebrafish
humanized embryos/larvae one of the most convenient strategies
for pharmaceutical industries. Cornet et al. suggest the use of
CRISPR/Cas9 to facilitate this procedure, which could provide
new insights to perform preclinical target validation, with the
advantage of providing a dual view due to the possibility
of evaluating drug toxicity and drug efficacy simultaneously
(Cornet et al., 2018).
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